Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer — Dec 6th, 2024

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer respond to current therapies, researchers reported on Thursday at the Society of Urologic Oncology meeting in Dallas....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer — Dec 6th, 2024

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer respond to current therapies, researchers reported on Thursday at the Society of Urologic Oncology meeting in Dallas....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Ferrari has Formula One in its DNA, CEO says after Cadillac supply deal — Dec 10th, 2024

Ferrari Chief Executive Benedetto Vigna said the luxury sportscar maker was "very proud" of a deal to supply engines and gearboxes to a new Cadillac Formula One team in a multi-year agreement from 2026 the company announced earlier on Tuesday....

DNA testing company Nebula accused of violating privacy in US lawsuit — Oct 11th, 2024

DNA testing company Nebula Genomics is facing a proposed federal class action in Chicago for allegedly violating an Illinois state law that restricts the collection and disclosure of personal genetic information....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer — Dec 6th, 2024

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer respond to current therapies, researchers reported on Thursday at the Society of Urologic Oncology meeting in Dallas....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer — Dec 6th, 2024

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer respond to current therapies, researchers reported on Thursday at the Society of Urologic Oncology meeting in Dallas....

Spanish scientists to shed light on mystery of Columbus origins, burial — Oct 10th, 2024

Spanish scientists said they will reveal details of the nationality of 15th-century explorer Christopher Columbus on Saturday, after using DNA analysis to tackle a centuries-old mystery....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture — Sep 24th, 2024

BOSTON and CHESTERFIELD, Mo., Sept. 24, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced its new partnership with NOVUS International, an innovator and leader in intelligent nutrition, to develo...

Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer — Dec 6th, 2024

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer respond to current therapies, researchers reported on Thursday at the Society of Urologic Oncology meeting in Dallas....

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln — Oct 23rd, 2024

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday....